FACULTY
Establishing Treatment Guidelines For Supportive Care In Patients With Cancer
Perspectives from Johns Hopkins on Local and National Implementation
Activity Date: March 2004  — Activity Info: Volume 4, (3B)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired) | Order Copy of Activity

 

Full Disclosure Policy Affecting CME Activities:
As sponsors accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the American Council on Pharmaceutical Education (ACPE), it is the policy of Johns Hopkins University School of Medicine and the University of Tennessee College of Pharmacy to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The Program Director and Participating Faculty reported the following:

PROGRAM DIRECTOR

    Jerry L. Spivak, MD
    Professor of Medicine and Oncology
    Johns Hopkins University School of Medicine
    Baltimore, Maryland
    Dr Spivak reports serving as a consultant to Amgen Inc, Novartis Corporation, Ortho Biotech, Roche, and Shire Pharmaceuticals Group plc.

PARTICIPATING FACULTY

    John H. Fetting III, MD
    Associate Director of Clinical Practice
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Associate Professor of Oncology and Medicine
    Johns Hopkins University School of Medicine
    Baltimore, Maryland
    Dr Fetting reports having no financial or advisory relationships with corporate
    organizations related to this activity.

    Stephen J. Noga, MD, PhD
    Director, Division of Hematology and Medical Oncology
    Alvin and Lois Lapidus Cancer Institute
    Sinai Hospital of Baltimore
    Associate Professor of Oncology and Pathology
    Johns Hopkins University School of Medicine
    Baltimore, Maryland
    Dr Noga reports serving as a consultant to Amgen Inc, Aventis Pharmaceuticals Inc, Gambro BCT, Inc, Idec, Novartis Corporation, and Ortho Biotech.

Notice:
In accordance with the ACCME, ANCC, and the ACPE Standards for Commercial Support, the audience is advised that one or more articles in this continuing medical education activity may contain reference(s) to unlabeled or unapproved uses of drugs or devices.

Faculty have indicated that they have not referenced unlabeled/unapproved uses of drugs or devices.

Advanced Studies in Medicine provides disclosure information from contributing authors, lead presenters, and participating faculty. Advanced Studies in Medicine does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies.

     
Home | Contact Us | View Account | Need Help?